Company Quick10K Filing
Original Source Music
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-18
10-K 2019-12-31 Filed 2020-04-09
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-07-29
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-11
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-18
10-K 2017-12-31 Filed 2018-04-23
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-28
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-24
10-K 2015-12-31 Filed 2016-04-14
8-K 2020-03-30
8-K 2019-10-02
8-K 2019-05-13
8-K 2018-04-13
8-K 2018-03-23

Original Source Music Financials

OSMU Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703,462,000 4,932,953,000 139,834,000 0 -9,707,897,000 -9,659,520,000 -395,458,000
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240,249,000 43,296,964,000 1,764,009,000 374,238,000 -25,717,337,000 -18,297,230,000 -540,256,000
Poverty Dignified (POVD) 0.0 -4,053% 49,338,000 3,079,595,000 0 0 -1,999,816,000 -1,786,224,000 -40,929,000
Zhong Ya (WLUC) 0.0 0 62,889,000 0 0 -561,596,000 -561,596,000 -2,000
Weyland Tech (WEYL) 18% 2.2 -24% 11,699,111,000 2,217,605,000 24,630,065,000 4,371,806,000 -2,778,623,000 -2,702,174,000 -5,820,631,000
Longbau (LNGB) 4% -1.0 2% 10,659,548,000 10,135,830,000 4,882,008,000 209,757,000 164,602,000 221,914,000 -232,744,000
Scandium International Mining (SCY) 0.1 -171% 956,938,000 303,212,000 0 0 -1,636,126,000 -1,634,396,000 -219,146,000
Aprea Therapeutics (APRE) 8.4 -11% 57,336,058,000 9,942,725,000 0 0 -6,249,419,000 -6,249,419,000 -52,334,104,000
IntelliSense Solutions (INLL) 0.0 -7,286% 2,442,000 272,894,000 0 0 -177,936,000 -163,709,000 -2,444,000
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000,000,000 403,121,000,000,000 37,348,000,000,000 0 4,559,000,000,000 4,960,000,000,000 -8,986,000,001,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4,412,000 323,686,000 0 0 -28,634,000 -17,937,000 -4,414,000
Ando Holdings (ANDO) 1.1 -74% 73,214,000 159,843,000 0 0 -54,299,000 -53,972,000 -60,816,000
Po Yuen Cultural (POYE) 0.0 -1,973% 1,000,000 68,122,000 0 0 -19,731,000 -19,731,000 -2,000
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218,459,000 6,588,633,000 0 0 -701,078,000 -701,078,000 -10,879,000
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,577,822,000 65,986,000 14,700,000 0 -314,665,000 -314,640,000 -238,429,000
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130,000,000 54,472,808,000,000 0 0 132,964,000,000 1,095,234,000,000 32,380,960,999,000
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,276,504,000 5,549,239,000 -688,891,000 1,137,086,000 -4,981,415,000
Original Source Music (OSMU) 0.0 743,400% 35,313,000 0 0 -7,434,000 -7,434,000 -2,000
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076,020,000 1,126,459,000 0 0 0 4,713,000 -2,000
JiaLiJia Group (RZZN) 0.0 -1,721% 4,000,000 139,328,000 0 0 -68,826,000 -68,826,000 -2,000

Balance Sheet ($)2015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,838,0001,816,0004,277,0003,076,000842,000888,000789,000685,000567,0001,0000000
Accounts Receivable
Inventory
PP&E
Assets1,838,0001,816,0004,277,000576,000842,000888,000789,0001,685,0001,067,0001,0000
Accounts Payable
Long-Term Debt10,956,00012,483,000
Liabilities19,821,00018,669,00021,807,00025,485,00029,786,00041,391,00047,941,00056,135,00069,010,0004,201,00015,520,00023,943,00027,879,00030,711,00034,614,00035,313,000
Stockholders' Equity-17,983,000-16,853,000-17,530,000-24,909,000-28,944,000-40,503,000-47,152,000-54,450,000-67,943,000-4,200,000-15,520,000-23,943,000-27,879,000-30,711,000-34,614,000-35,313,000
Income Statement ($)2015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue102,00091,00050,000139,000121,00075,00075,00010,000-65,0000000
Cost of Revenue
Gross Profit
R&D
SG&A125,000130,000951,000177,000175,000174,0001,939,000594,000-1,345,000635,0007,000074,000
Tax00000000000000
Net Income-4,573,000-10,591,000-8,878,000-5,544,000-6,639,000-7,649,000-7,298,000-12,493,000-667,000-4,689,000-8,423,000-2,832,000-3,903,000-699,000
Cash Flow ($)2015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-5,725,000-7,453,000-2,701,000-2,833,000-2,554,000-6,422,000-6,164,000-8,493,000-566,000-14,321,000000
Cash Investing00090,000000
Cash Financing5,703,0009,914,0001,500,000-1,000,00011,370,000-2,447,0006,060,0008,375,000014,320,0000